Terms: = Uterine cancer AND HNF1A, HNF1, 6927, ENSG00000135100, TCF1, MODY3, P20823, LFB1
17 results:
1. Targeting CD96 overcomes PD-1 blockade resistance by enhancing CD8+ TIL function in cervical cancer.
Wang Y; Wang C; Qiu J; Qu X; Peng J; Lu C; Zhang M; Zhang M; Qi X; Li G; Hua K
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35288463
[TBL] [Abstract] [Full Text] [Related]
2. Guizhi Fuling Capsule inhibits uterine fibroids growth by modulating Med12-mediated Wnt/β-Catenin signaling pathway.
Chen L; Chen H; Yang Q; Jiang Y; Liu L; Yu H; Chen Y; Li J; Chen N; Wang H; Wang Q
J Ethnopharmacol; 2022 May; 290():115115. PubMed ID: 35181487
[TBL] [Abstract] [Full Text] [Related]
3. Clinical factors and biomarker profiles associated with patient outcome in endometrioid ovarian carcinoma - Emphasis on tumor grade.
Soovares P; Pasanen A; Similä-Maarala J; Bützow R; Lassus H
Gynecol Oncol; 2022 Jan; 164(1):187-194. PubMed ID: 34711431
[TBL] [Abstract] [Full Text] [Related]
4. Hepatocyte nuclear factor 1 beta: A perspective in cancer.
Chandra S; Srinivasan S; Batra J
Cancer Med; 2021 Mar; 10(5):1791-1804. PubMed ID: 33580750
[TBL] [Abstract] [Full Text] [Related]
5. Transcriptome analysis uncovers the diagnostic value of miR-192-5p/hnf1a-AS1/VIL1 panel in cervical adenocarcinoma.
Xu J; Zou J; Wu L; Lu W
Sci Rep; 2020 Oct; 10(1):16584. PubMed ID: 33024199
[TBL] [Abstract] [Full Text] [Related]
6. TMEM48 promotes cell proliferation and invasion in cervical cancer via activation of the Wnt/β-catenin pathway.
Jiang XY; Wang L; Liu ZY; Song WX; Zhou M; Xi L
J Recept Signal Transduct Res; 2021 Aug; 41(4):371-377. PubMed ID: 32896205
[TBL] [Abstract] [Full Text] [Related]
7. Immunohistochemical Markers With Potential Diagnostic, Prognostic, and Therapeutic Significance in uterine Carcinosarcoma: A Clinicopathologic Study of 43 Cases.
Jones TE; Pradhan D; Dabbs DJ; Bhargava R; Onisko A; Jones MW
Int J Gynecol Pathol; 2021 Jan; 40(1):84-93. PubMed ID: 31855950
[TBL] [Abstract] [Full Text] [Related]
8. DNMT1 recruited by EZH2-mediated silencing of miR-484 contributes to the malignancy of cervical cancer cells through MMP14 and hnf1a.
Hu Y; Wu F; Liu Y; Zhao Q; Tang H
Clin Epigenetics; 2019 Dec; 11(1):186. PubMed ID: 31810492
[TBL] [Abstract] [Full Text] [Related]
9. Molecular biomarkers predicting early development of endometrial carcinoma: A pilot study.
Lupini L; Scutiero G; Iannone P; Martinello R; Bassi C; Ravaioli N; Soave I; Bonaccorsi G; Lanza G; Gafà R; Loizzi V; Negrini M; Greco P
Eur J Cancer Care (Engl); 2019 Nov; 28(6):e13137. PubMed ID: 31412428
[TBL] [Abstract] [Full Text] [Related]
10. Germ cell tumour growth patterns originating from clear cell carcinomas of the ovary and endometrium: a comparative immunohistochemical study favouring their origin from somatic stem cells.
Nogales FF; Prat J; Schuldt M; Cruz-Viruel N; Kaur B; D'Angelo E; Matias-Guiu X; Vidal A; McCluggage WG; Oosterhuis JW
Histopathology; 2018 Mar; 72(4):634-647. PubMed ID: 29106744
[TBL] [Abstract] [Full Text] [Related]
11. Genetic alterations in endometrial cancer by targeted next-generation sequencing.
Chang YS; Huang HD; Yeh KT; Chang JG
Exp Mol Pathol; 2016 Feb; 100(1):8-12. PubMed ID: 26626801
[TBL] [Abstract] [Full Text] [Related]
12. Integrative bioinformatics links hnf1B with clear cell carcinoma and tumor-associated thrombosis.
Cuff J; Salari K; Clarke N; Esheba GE; Forster AD; Huang S; West RB; Higgins JP; Longacre TA; Pollack JR
PLoS One; 2013; 8(9):e74562. PubMed ID: 24040285
[TBL] [Abstract] [Full Text] [Related]
13. Characterization of P1 promoter activity of the beta-galactoside alpha2,6-sialyltransferase I gene (siat 1) in cervical and hepatic cancer cell lines.
Milflores-Flores L; Millán-Pérez L; Santos-López G; Reyes-Leyva J; Vallejo-Ruiz V
J Biosci; 2012 Jun; 37(2):259-67. PubMed ID: 22581331
[TBL] [Abstract] [Full Text] [Related]
14. Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management.
Mandai M; Yamaguchi K; Matsumura N; Baba T; Konishi I
Int J Clin Oncol; 2009 Oct; 14(5):383-91. PubMed ID: 19856044
[TBL] [Abstract] [Full Text] [Related]
15. Mutation of tcf1 encoding hepatocyte nuclear factor 1alpha in gynecological cancer.
Rebouissou S; Rosty C; Lecuru F; Boisselier S; Bui H; Le Frere-Belfa MA; Sastre X; Laurent-Puig P; Zucman-Rossi J
Oncogene; 2004 Sep; 23(45):7588-92. PubMed ID: 15326484
[TBL] [Abstract] [Full Text] [Related]
16. The transactivation potential of variant hepatocyte nuclear factor 1 is modified by alternative splicing.
Ringeisen F; Rey-Campos J; Yaniv M
J Biol Chem; 1993 Dec; 268(34):25706-11. PubMed ID: 8245006
[TBL] [Abstract] [Full Text] [Related]
17. Liver-specific expression of human insulin-like growth factor binding protein 1: functional role of transcription factor hnf1 in vivo.
Babajko S; Tronche F; Groyer A
Proc Natl Acad Sci U S A; 1993 Jan; 90(1):272-6. PubMed ID: 7678342
[TBL] [Abstract] [Full Text] [Related]
